ArticleGenome medicine2022
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.
Enrico Berrino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it